Overview
Peter Crow is a Hematologist Oncology specialist and an Oncologist in Concord, New Hampshire. Dr. Crow is rated as an Experienced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, and Richter Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
250 Pleasant St, Concord, NH 03301
Dana-Farber Cancer Institute, Inc.
Sanggyu Bae is a Hematologist Oncology specialist and a Hematologist in Londonderry, New Hampshire. Dr. Bae is rated as an Advanced provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Sideroblastic Anemia, and Childhood Iron Deficiency Anemia. Dr. Bae is currently accepting new patients.
Lahey Clinic Inc
Tarun Kewalramani is a Hematologist and an Oncologist in Burlington, Massachusetts. Dr. Kewalramani is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kewalramani is currently accepting new patients.
Henry Sonneborn is a Hematologist Oncology provider in Dover, New Hampshire. Dr. Sonneborn is rated as a Distinguished provider by MediFind in the treatment of Sideroblastic Anemia. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Throat Cancer, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Crow isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Crow isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Lung CancerDr. Crow isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Crow isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Crow isDistinguished. Learn about Pleuropulmonary Blastoma.
- Richter SyndromeDr. Crow isDistinguished. Learn about Richter Syndrome.
- Advanced
- Acute Eosinophilic PneumoniaDr. Crow isAdvanced. Learn about Acute Eosinophilic Pneumonia.
- AgranulocytosisDr. Crow isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Crow isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Crow isAdvanced. Learn about Angiosarcoma.
- AstrocytomaDr. Crow isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Crow isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Crow isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Crow isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Crow isExperienced. Learn about Acute Myelomonocytic Leukemia.